Clinical Publication
RSSArticles
-
National Alzheimer’s Plan Updated with New Focus on Healthy Aging
Feds add sixth goal in the ninth version of this annually released report.
-
First Injectable Pre-Exposure Prophylaxis Receives FDA Approval
Researchers hope this long-acting solution every will boost PrEP adherence rates among those at risk for contracting HIV.
-
Dietary Modifications with Linoleic Acid Can Have an Effect on Gut and Brain Inflammation
This study will widen the scope of discussion on the treatment of neurological disorders. Nutritional supplements need to be discussed with caution until clear recommendations can be given based on clinical trials and other strong evidence of efficacy without significant side effects.
-
Parabacteroides, Flavonoid-Rich Foods, and Lower Blood Pressure
Results showed that higher dietary intake of total flavonoids, specifically anthocyanins and proanthocyanidins polymers, were associated with statistically significant lower systolic blood pressure and pulse pressure.
-
Birth Hospital ZIP Code and Neonatal Outcomes in Very Preterm Birth
This work may serve as a reminder to the healthcare provider of the importance of developing a complete and nuanced understanding of a patient and recognizing that environment often affects healthcare risk factors and wellness efforts.
-
Analysts Suggest U.S. COVID-19 Vaccination Program Prevented Millions of Hospitalizations, Deaths
The pandemic has taken a heavy toll, but the damage could be so much worse without vaccines.
-
CMS, HHS Offer Multipronged Approach to Improving Maternal Health
Biden administration asks hospitals to review policies and procedures, calls on states to expand postpartum coverage under Medicaid and CHIP.
-
Tearing Down Barriers to Medical Error Reporting
Lack of time, complex systems prevent staff from reporting medical errors, near-misses more often.
-
Tailoring Dietary Recommendations to Protect Cognitive Health
Preventing inflammation as patients age is becoming key focus of lowering dementia risk.
-
AAN Offers Ethical Guidance on Alzheimer’s Drug
Neurology experts issue caution on costs, side effects regarding the approved-but-controversial Aduhelm.